In response to the CDC’s release of clinical criteria to guide the evaluation of patients under investigation (PUI) for Wuhan coronavirus (2019-nCoV), Bright.md updated its Upper Respiratory Infection (URI) SmartExam™ modules to include coronavirus screening. SmartExam will automatically escalate positive screenings for further evaluation as well as continue to screen for flu diligently as we fly through one of the most destructive flu seasons in recent history.
Editor's Note: This publication originally appeared on Bright.md's website.
“We are doing everything we can to support our health system partners as they stay in front of the coronavirus scare, including a screening update that will use CDC insights to triage people who have higher risk for coronavirus,” said Dr. Ray Costantini, co-founder and CEO of Bright.md. “That said, coronavirus is a pandemic threat that is making headlines, with only five documented cases in the US. As a trained medical doctor, it’s important to remind people not to get caught up in a panic. The real threat facing a greater number of Americans is still the flu – especially those who haven’t yet been vaccinated this year. We’re up to at least 8,200 flu deaths already this year. There’s still time to get that shot.”
So far this past month, 11.5% of SmartExam URI module visits through Bright.md health system partners across the nation were flu-driven. SmartExam, Bright.md’s award-winning asynchronous virtual care platform, provides convenient online access to primary and urgent care for low-acuity conditions from anywhere – a home, office, car, or even bed. Click here to continue>>
News from our Partner